Related Experiment Video

Updated: Jul 2, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Advancing Cancer Therapy: Nano-Therapeutics for Precision Targeting of the Tumor Microenvironment

Sachin M Mendhi1, Kuldeep Vinchurkar2, Sheetal Mane3

  • 1Department of Pharmacology, Dadasaheb Balpande College of Pharmacy, Nagpur, 440037, Maharashtra, India.

Pharmaceutical Nanotechnology
|July 1, 2026
PubMed

Insights

Nanotechnology offers new cancer treatments targeting the tumor microenvironment (TME). These nano-therapeutics enhance efficacy and reduce side effects by interacting with TME components, improving patient outcomes.

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Cancer treatment faces challenges due to the complex tumor microenvironment (TME).
  • Traditional therapies often show limited efficacy against the TME, leading to resistance and relapse.
  • Nanotechnology presents novel strategies for targeted cancer therapy.

Purpose of the Study:

  • To provide a comprehensive review of nano-therapeutics designed to target the TME.
  • To highlight the mechanisms, progress, and future prospects of TME-targeting nano-therapeutics.
  • To elucidate the interplay between nanotherapeutics and TME constituents for improved treatment outcomes.

Main Methods:

  • Review of current literature on nanotechnology in cancer therapy.
  • Analysis of nano-therapeutic mechanisms targeting immune cells, stromal cells, and extracellular matrix within the TME.
  • Exploration of combination strategies involving nano-therapeutics and conventional treatments.

Main Results:

  • Nano-therapeutics demonstrate potential in overcoming TME-related treatment resistance.
  • Targeting specific TME components with nanotherapeutics can enhance drug delivery and efficacy.
  • Combination therapies show promise for a multi-faceted approach to cancer treatment.

Conclusions:

  • Nano-therapeutics represent a promising frontier in oncology, offering targeted approaches to the TME.
  • Understanding the interaction between nanotherapeutics and the TME is crucial for optimizing cancer treatment strategies.
  • Further research into nano-therapeutics and combination therapies could significantly improve cancer patient survival and quality of life.
Keywords:
Cancer treatmentcancer resistancedrug delivery systemsimmunotherapynano-therapeuticsnanomedicinetargeted therapytumour microenvironment

More Related Videos

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...